CD59 and lymphoma: Bispecific antibodies targeting both CD20 and CD55 or CD20 and CD59 were also shown to potentiate the CDC of CD20-positive lymphoma cells in vitro and to prevent the growth of human lymphoma cells in SCID mice (202).